Research progress on platelet-rich fibrin derivatives

doi:10.7518/hxkq.2019.06.016

Abstract

CLC Number:

Chang Yaoren, Liu Chun, Yin Lihua. Research progress on platelet-rich fibrin derivatives[J]. West China Journal of Stomatology, 2019, 37(6): 660-665.

References 56

[1]	Dohan DM, Choukroun J, Diss A , et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part Ⅰ: technological concepts and evolution[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006,101(3):e37-e44. doi: 10.1016/j.tripleo.2005.07.008 URL pmid: 16504849
[2]	He L, Lin Y, Hu X , et al. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009,108(5):707-713. doi: 10.1016/j.tripleo.2009.06.044 URL pmid: 19836723
[3]	Plachokova AS, van den Dolder J, Stoelinga PJ , et al. The bone regenerative effect of platelet-rich plasma in combination with an osteoconductive material in rat cranial defects[J]. Clin Oral Implan Res, 2006,17(3):305-311. doi: 10.1111/j.1600-0501.2005.01208.x URL pmid: 16672026
[4]	Dohan Ehrenfest DM, Del Corso M, Diss A , et al. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane[J]. J Periodontol, 2010,81(4):546-555. doi: 10.1902/jop.2009.090531 URL
[5]	Dohan DM, Choukroun J, Diss A , et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part Ⅲ: leucocyte activation: a new feature for platelet concentrates[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2006,101(3):e51-e55. doi: 10.1016/j.tripleo.2005.07.010 URL pmid: 16504851
[6]	Dohan Ehrenfest DM, de Peppo GM, Doglioli P , et al. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies[J]. Growth Factors, 2009,27(1):63-69. doi: 10.1080/08977190802636713 URL
[7]	Dohan Ehrenfest DM, Diss A, Odin G , et al. In vitro effects of Choukroun’s PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2009,108(3):341-352. doi: 10.1016/j.tripleo.2009.04.020 URL pmid: 19589702
[8]	Dohan Ehrenfest DM ,Doglioli P,de Peppo GM, et al. Choukroun’s platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way[J]. Arch Oral Biol, 2010,55(3):185-194. doi: 10.1016/j.archoralbio.2010.01.004 URL
[9]	Dohan Ehrenfest DM, Rasmusson L, Albrektsson T . Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)[J]. Trends Biotechnol, 2009,27(3):158-167. doi: 10.1016/j.tibtech.2008.11.009 URL
[10]	O’Connell SM . Safety issues associated with platelet-rich fibrin method[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2007,103(5):587. doi: 10.1016/j.tripleo.2007.03.017 URL pmid: 17466883
[11]	Tunali M, Özdemir H ,Küçükodaci Z , et al. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate[J]. Br J Oral Maxillofac Surg, 2013,51(5):438-443. doi: 10.1016/j.bjoms.2012.08.003 URL pmid: 22951383
[12]	Tunali M, Ozdemir H, Kucukodaci Z , et al. Titanium prepared platelet-rich fibrin (TPRF): a third-generation patelet concentrate. A pilot study[J]. J Clin Periodontol, 2012,39(1):126.
[13]	Choukroun J . Advanced PRF & i-PRF: platelet concentrates or blood concentrates[J]. J Periodont Med Clin Pract, 2014,1(1):3. doi: 10.1186/s13104-019-4750-x URL pmid: 31685012
[14]	Lucarelli E, Beretta R, Dozza B , et al. A recently developed bifacial platelet-rich fibrin matrix[J]. Eur Cell Mater, 2010,20(1):13-23. doi: 10.22203/ecm.v020a02 URL pmid: 20597062
[15]	Zhang DS, Eggleton CD, Arola DD . Evaluating the mechanical behavior of arterial tissue using digital image correlation[J]. Exp Mech, 2002,42(4):409-416. doi: 10.1007/BF02412146 URL
[16]	Zhang GA, Ning FG, Zhao NM . Biomechanical properties of four dermal substitutes[J]. Chin Med J, 2007,120(16):1454-1455. URL pmid: 17825178
[17]	Mazzucco L, Balbo V, Cattana E , et al. Not every PRP-gel is born equal Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet ^®, RegenPRP-Kit ^®, Plateltex ^® and one manual procedure [J]. Vox Sanguinis, 2009,97(2):110-118. doi: 10.1111/j.1423-0410.2009.01188.x URL pmid: 19392780
[18]	O’Connell SM, Impeduglia T, Hessler K , et al. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers[J]. Wound Repair Regen, 2008,16(6):749-756. doi: 10.1111/j.1524-475X.2008.00426.x URL pmid: 19128245
[19]	Dohan Ehrenfest DM, Pinto NR, Pereda A , et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane [J]. Platelets, 2018,29(2):171-184. doi: 10.1080/09537104.2017.1293812 URL pmid: 28437133
[20]	Mazzucco L, Balbo V, Cattana E , et al. Platelet-rich plasma and platelet gel preparation using Plateltex ^® [J]. Vox Sanguinis, 2008,94(3):202-208. doi: 10.1111/j.1423-0410.2007.01027.x URL pmid: 18179680
[21]	Masuki H, Okudera T, Watanebe T , et al. Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF)[J]. Int J Implant Dent, 2016. doi. org/10.1186/s40729-016-0052-4. doi: 10.1186/s40729-019-0192-4 URL pmid: 31749041
[22]	Fujioka-Kobayashi M, Miron RJ, Hernandez M , et al. Optimized platelet-rich fibrin with the low-speed concept: growth factor release, biocompatibility, and cellular response[J]. J Periodontol, 2017,88(1):112-121. doi: 10.1902/jop.2016.160443 URL pmid: 27587367
[23]	Miron RJ, Fujioka-Kobayashi M, Hernandez M , et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry[J]. Clin Oral Invest, 2017,21(8):2619-2627. doi: 10.1007/s00784-017-2063-9 URL pmid: 28154995
[24]	Mourão CF, Valiense H, Melo ER , et al. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: technical note[J]. Rev Col Bras Cir, 2015,42(6):421-423. doi: 10.1590/0100-69912015006013 URL pmid: 26814997
[25]	Tunali M, Özdemir H, Küçükodacı Z , et al. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate[J]. Br J Oral Maxillofac Surg, 2013,51(5):438-443. doi: 10.1016/j.bjoms.2012.08.003 URL pmid: 22951383
[26]	Tunali M, Özdemir H ,Küçükodacı Z, et al. A novel platelet concentrate: titanium-prepared platelet-rich fibrin[J]. Biomed Res Int, 2014,2014:1-7. doi: 10.4103/JCD.JCD_216_18 URL pmid: 30820078
[27]	Aggour RL, Sabry HA, Hassan GS . In vitro evaluation of mechanical and structural properties of leukocyte-platelet-rich fibrin and platelet-rich fibrin martix[J]. Egypt Dent J, 2017,63(2):305-313.
[28]	Simon B, Zatcoff A, Kong JJ , et al. Clinical and histological comparison of extraction socket healing following the use of autologous platelet-rich fibrin matrix (PRFM) to ridge preservation procedures employing demineralized freeze dried bone allograft material and membrane[J]. Open Dent J, 2009,3(1):92-99. doi: 10.2174/1874210600903010092 URL
[29]	Simon BI, Gupta P, Tajbakhsh S . Quantitative evaluation of extraction socket healing following the use of autologous platelet-rich fibrin matrix in humans[J]. Int J Periodont Restorat Dent, 2011,31(3):285-295. URL pmid: 21556385
[30]	O’Connell SM, Hessler K, Dardik H . Cascade ^® autologous system platelet-rich fibrin matrix in the treatment of chronic leg ulcers [J]. Adv Wound Care, 2012,1(1):52-55. doi: 10.1089/wound.2011.0290 URL
[31]	Dohan Ehrenfest DM, Bielecki T, Jimbo R , et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF)[J]. Curr Pharma Biotech, 2012,13(7):1145-1152. doi: 10.2174/138920112800624382 URL pmid: 21740377
[32]	Lollobrigida M, Maritato M, Bozzuto G , et al. Biomimetic implant surface functionalization with liquid L-PRF products: in vitro study[J]. Biomed Res Int, 2018. doi. org/10.1155/2018/9031435. doi: 10.1155/2019/9824964 URL pmid: 31737682
[33]	Öncü E, Bayram B, Kantarcı A , et al. Positive effect of platelet rich fibrinon osseointegration[J]. Med Oral Patol Oral Cir Bucal, 2016,21(5):e601. doi: 10.4317/medoral.21026 URL pmid: 27475686
[34]	Neiva RF, Gil LF, Tovar N , et al. The synergistic effect of leukocyte platelet-rich fibrin and micrometer/nanometer surface texturing on bone healing around immediately placed implants: an experimental study in dogs[J]. Biomed Res Int, 2016,2016:1-9. doi: 10.1155/2016/9507342 URL pmid: 28042577
[35]	Bastami F, Khojasteh A . Use of leukocyte-and platelet-rich fibrin for bone regeneration: a systematic review[J]. Regen Reconstr Restor, 2016,1(2):47-68. doi: 10.1155/2019/9148183 URL pmid: 31531371
[36]	del Corso M, Sammartino G, Dohan Ehrenfest DM . Letter to the editor: Re: “clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study”[J]. J Periodontol, 2009,80(11):1694-1697. doi: 10.1902/jop.2009.090253 URL pmid: 19905939
[37]	Temmerman A, Cleeren GJ, Castro AB , et al. L-PRF for increasing the width of keratinized mucosa around implants: a split-mouth, randomized, controlled pilot clinical trial[J]. J Periodont Res, 2018,53(5):793-800. doi: 10.1111/jre.12568 URL pmid: 29858875
[38]	Kim JW, Kim SJ, Kim MR . Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study[J]. Br J Oral Maxillofac Surg, 2014,52(9):854-859. doi: 10.1016/j.bjoms.2014.07.256 URL pmid: 25138613
[39]	Ghanaati S, Booms P, Orlowska A , et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells[J]. J Oral Implant, 2014,40(6):679-689. doi: 10.1563/aaid-joi-D-14-00138 URL pmid: 24945603
[40]	Cabaro S ,D’Esposito V, Gasparro R,et al. White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds[J]. Platelets, 2018,29(5):463-467. doi: 10.1080/09537104.2017.1319046 URL pmid: 28635382
[41]	Titirinli K, Tekin U, Atıl F , et al. Evaluation of advanced platelet rich fibrin (A-PRF) on bone healing. is it better than old version? A histological animal study[J]. J Biomater Tissue Eng, 2017,7(6):478-483. doi: 10.1166/jbt.2017.1592 URL
[42]	Kalash S, Aboelsaad N, Shokry M , et al. The efficiency of using advanced PRF-xenograft mixture around immediate implants in the esthetic zone: a randomized controlled clinical trial[J]. J Osseointegrat, 2017,9(4):317-322.
[43]	Sameera S, Nagasri M, Aravind Kumar P , et al. Comparison of two surgical techniques in the treatment of multiple gingival recessions sandwiched with a combination of A-PRF and L-PRF[J]. Saudi Dent J, 2018,30(3):183-189. doi: 10.1016/j.sdentj.2018.03.002 URL pmid: 29942101
[44]	Varela HA, Souza JC, Nascimento RM , et al. Injectable platelet rich fibrin: cell content, morphological, and protein characterization[J]. Clin Oral Investig, 2019,23(3):1309-1318. doi: 10.1007/s00784-018-2555-2 URL pmid: 30003342
[45]	Wang XZ, Zhang YF, Choukroun J , et al. Behavior of gingival fibroblasts on titanium implant surfaces in combination with either injectable-PRF or PRP[J]. Int J Mol Sci, 2017,18(2):331. doi: 10.1002/prp2.546 URL pmid: 31763045
[46]	Wang XZ, Zhang YF, Choukroun J , et al. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma[J]. Platelets, 2018,29(1):48-55. doi: 10.1080/09537104.2017.1293807 URL pmid: 28351189
[47]	Abd El Raouf M, Wang XZ, Miusi S , et al. Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma[J]. Platelets, 2017,30(2):213-221. doi: 10.1080/09537104.2017.1401058 URL pmid: 29240523
[48]	Miron RJ, Bishara M, Choukroun J . Basics of platelet-rich fibrin therapy[J]. Dent Today, 2017,36(4):74-76. URL pmid: 29235312
[49]	Santos JC, Cruz Tórtora GD, Andrade CF , et al. Reconstruction of atrophic maxilla with the use of allogenic bone graft and platelet concentrate—clinical case report[J]. RSBO, 2018,1(4):238-243. doi: 10.21726/rsbo.v1i4.551 URL
[50]	Chenchev IL, Ivanova VV, Neychev DZ , et al. Application of platelet-rich fibrin and injectable platelet-rich fibrin in combination of bone substitute material for alveolar ridge augmentation—a case report[J]. Folia Medica, 2017,59(3):362-366. doi: 10.1515/folmed-2017-0044 URL pmid: 28976904
[51]	Karde P, Sethi K, Mahale S , et al. Comparative evaluation of platelet count and antimicrobial efficacy of injectable platelet-rich fibrin with other platelet concentrates: an in vitro study[J]. J Indian Soc Periodontol, 2017,21(2):97-101. doi: 10.4103/jisp.jisp_201_17 URL pmid: 29398852
[52]	Takemoto S, Yamamoto T, Tsuru K , et al. Platelet adhesion on titanium oxide gels: effect of surface oxidation[J]. Biomaterials, 2004,25(17):3485-3492. doi: 10.1016/j.biomaterials.2003.10.070 URL
[53]	Tunali M, Özdemir H ,Küçükodac Z, et al. Role of vascular endothelial growth factor and alkaline phosphatase in T-prf induced bone formation[J]. Clin Oral Implant Res, 2014,25(suppl 10):274. doi: 10.1111/clr.12458_1 URL pmid: 25244660
[54]	Firatli E, Tunali M, Özdemir H , et al. Osteopontin expression in T-prf induced bone formation[J]. Clin Oral Implant Res, 2014,25(suppl 10):275. doi: 10.1111/clr.12458_1 URL pmid: 25244660
[55]	Uzun BC, Ercan E, Tunalı M . Effectiveness and predictability of titanium-prepared platelet-rich fibrin for the management of multiple gingival recessions[J]. Clin Oral Investig, 2017. doi. org/10.1007/s00784-017-2211-2. doi: 10.1007/s00784-019-03122-5 URL pmid: 31760476
[56]	Choukroun J, Ghanaati S . Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept[J]. Eur J Trauma Emerg Surg, 2018,44(1):87-95. doi: 10.1007/s00068-017-0767-9 URL pmid: 28283682

Research progress on platelet-rich fibrin derivatives

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 56

Related Articles 2

Recommended Articles

Metrics

Comments

[1]	Yu Haiyang, Li Junying.. The concept, clinical design and transfer application of target restoration space [J]. West China Journal of Stomatology, 2015, 33(2): 111-114.
[2]	Cao Yangpei, Zhou Xuedong, Shi Wenyuan. New progress in research of Granulicatella species [J]. West China Journal of Stomatology, 2011, 29(06): 665-669.